Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Mediceo to Cut Costs Taking Advantage of ALCs
March 22, 2010
- Takara Bio Ties Up with Univ. of Pennsylvania for HIV Gene Therapy
March 22, 2010
- Morimoto Proposes Shared Manufacturing Site in Shanghai
March 22, 2010
- Pfizer Discontinues PIII Study of Figitumumab for Advanced NSCLC
March 22, 2010
- Will the Era of DI Pharmacists Arrive?
March 22, 2010
- VEGF Trap-Eye Improved Visual Acuity in Patients with DME: Bayer
March 22, 2010
- Symbicort Ranked No. 1 on GP Market
March 22, 2010
- WG to Be Created to Increase Self-Sufficiency Rate for Blood Products
March 22, 2010
- Booz & Company Proposes New Contract Manufacturing Business Model
March 22, 2010
- JMA Strongly Opposed to Promotion of “Integrated Medicine”
March 22, 2010
- Ajinomoto Pharm. to Set Out in April
March 22, 2010
- Vaccine-Related Societies to Create Consortium to Deal with Korosho
March 22, 2010
- Korosho Completes Hearings of Dispensing Pharmacy Chain Operators
March 22, 2010
- Requirements for High-Risk Drug Premium Explained by Korosho
March 22, 2010
- Quintiles Starts Tissue Testing Services in China
March 15, 2010
- Switch OTC Drugs Market Up 2.3% to ¥157.1 Bil. in 2009: Fuji-Keizai
March 15, 2010
- Suzuken Ties Up with Frontier for Dispensing Pharmacy Business
March 15, 2010
- Deepest Price Cuts for Lanbaxy/I'rom's Amlodipine Generics
March 15, 2010
- CareNet Obtains Patent on e-Detailing Service
March 15, 2010
- Sawai to Boost Sales to ¥74 Bil. by March 2012
March 15, 2010
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…